Valuation: Guizhou Bailing Group Pharmaceutical Co., Ltd.

Market Cap 6.22B 923M 797M 750M 682M 1.28B 88.44B 1.3B 8.8B 3.45B 44.23B 3.47B 3.39B 147B P/E 2024
193x
P/E 2025 -54.4x
Enterprise Value 7.1B 1.05B 909M 855M 778M 1.46B 101B 1.48B 10.03B 3.93B 50.45B 3.95B 3.87B 168B EV / Sales 2024
1.74x
EV / Sales 2025 2.23x
Free-Float
67.53%
Yield 2024 *
-
Yield 2025 -
1 day-0.65%
1 week-0.44%
Current month-0.87%
1 month+1.33%
3 months-6.17%
6 months+4.59%
Current year+4.83%
1 week 4.55
Extreme 4.55
4.85
1 month 4.36
Extreme 4.36
4.85
Current year 4.08
Extreme 4.08
5.47
1 year 4.08
Extreme 4.08
6.54
3 years 2.98
Extreme 2.98
8.8
5 years 2.98
Extreme 2.98
11.97
10 years 2.98
Extreme 2.98
25.12
Manager TitleAgeSince
Chief Executive Officer 56 2015-04-01
Director of Finance/CFO 41 2020-12-28
Corporate Officer/Principal 42 2014-01-26
Director TitleAgeSince
Chairman 56 2026-03-26
Director/Board Member 58 2007-12-24
Director/Board Member 42 2014-01-26
Date Insider Type Main position Quantity % Market Cap.
9/21/20 Sell

Chairman

1,940,600 0.2495%
9/18/20 Sell

Director

3,670,000 0.4719%
9/18/20 Sell

Chairman

296,500 0.0381%
Change 5-day change 1-year change 3-year change Capi.($)
-0.65%-0.44%-24.75%-42.35% 923M
-0.60%-2.62%-12.91%-6.04% 13.1B
-1.10%-2.89%-33.62%-57.05% 4.92B
-0.02%-3.97%+2.16%-0.35% 4.87B
-1.23%-0.41%+4.15%-26.61% 4.16B
-0.83%-2.53%-26.26%+3.70% 3.55B
+0.20%-0.90%-9.74%+15.54% 3.41B
-0.99%-6.39%-9.84%-8.50% 3.28B
-1.93%-0.06%-15.11%-15.88% 2.47B
-4.58%+6.02%-0.65%-10.37% 1.72B
Average -1.17%-1.99%-12.66%-14.79% 4.24B
Weighted average by Cap. -0.88%-2.01%-12.42%-12.50%

Financials

2024 2025
Net sales 3.83B 567M 490M 461M 419M 788M 54.35B 800M 5.41B 2.12B 27.18B 2.13B 2.08B 90.54B 3.05B 452M 390M 367M 334M 628M 43.32B 637M 4.31B 1.69B 21.66B 1.7B 1.66B 72.16B
Net income 33.62M 4.99M 4.31M 4.05M 3.68M 6.93M 478M 7.03M 47.53M 18.63M 239M 18.72M 18.31M 796M -104M -15.48M -13.37M -12.58M -11.43M -21.5M -1.48B -21.81M -148M -57.81M -742M -58.11M -56.84M -2.47B
Net Debt 1.4B 208M 179M 169M 153M 288M 19.9B 293M 1.98B 776M 9.95B 780M 763M 33.14B 875M 130M 112M 105M 95.79M 180M 12.43B 183M 1.24B 485M 6.22B 487M 476M 20.7B
Logo Guizhou Bailing Group Pharmaceutical Co., Ltd.
Guizhou Bailing Group Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development, production and sales of Miao medicine. The Company operates four segments. The Industrial segment is mainly engaged in the research and development, production and sales of Chinese patent medicine tablets, capsules and syrups. The Commercial segment is mainly engaged in drug distribution and big health business. The Medical Institution segment mainly operates diabetes hospitals. Other segment mainly provides Chinese medicinal materials and are engaged in organic fertilizer manufacturing, water production and supply and other businesses. The Company's products include Yindan Xinnaotong soft capsules, Kesuting syrup and capsules, Shuangyang Houbitong granules and non-Miao medicine products Jingan capsules, Vitamin C Yinqiao tablets, Xiaoer Chaigui antipyretic granules and other products. The Company mainly conducts its businesses in the domestic market.
Employees
5,715
Date Price Change Volume
26-08-18 CN¥4.560 -0.65% 5,855,000
26-08-17 CN¥4.590 -0.65% 5,815,500
26-08-14 CN¥4.620 -0.86% 8,975,100
26-08-13 CN¥4.660 +0.43% 17,290,800
26-08-12 CN¥4.640 +1.31% 8,100,200

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002424 Stock